Fractyl Health (GUTS) Assets (2023 - 2026)
Fractyl Health's (GUTS) quarterly Assets came in at $99.4 million in Q1 2026, up 19.68% YoY from $83.0 million in Q1 2025, and down 18.14% on a QoQ basis from $121.4 million in Q4 2025.
Fractyl Health (GUTS) Assets (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Assets data on file, last reported at $99.4 million in Q1 2026.
- Quarterly Assets rose 19.68% year-over-year to $99.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.4 million (up 19.68% YoY) and the FY2025 annual result came in at $121.4 million, up 12.33% from the prior year.
- Assets declined to $99.4 million in Q1 2026, from $121.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $163.5 million in Q1 2024 to a low of $62.0 million in Q2 2025.
- A 4-year average of $110.1 million and a median of $111.2 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets surged 41.81% — and 2025, when it sank 57.66%.
- Tracing GUTS's Assets over 4 years: stood at $76.2 million in 2023, then surged by 41.81% to $108.1 million in 2024, then grew by 12.33% to $121.4 million in 2025, then declined by 18.14% to $99.4 million in 2026.
- The last three Assets figures came in at $99.4 million (Q1 2026), $121.4 million (Q4 2025), and $114.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - | 81.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.98 Mn |
| Mar 31, 2026 | 99.39 Mn |
| Dec 31, 2025 | 121.40 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Jun 30, 2025 | 62.01 Mn |
| Mar 31, 2025 | 83.04 Mn |
| Dec 31, 2024 | 108.08 Mn |
| Sep 30, 2024 | 126.92 Mn |
| Jun 30, 2024 | 146.44 Mn |
| Mar 31, 2024 | 163.52 Mn |
| Dec 31, 2023 | 76.21 Mn |